2 April 2020 - Australians will no longer be able to access Truvada from, which is used for HIV treatment as well as for pre-exposure prophylaxis (PrEP), through the Pharmaceutical Benefits Scheme (PBS), however, the Australian Federation of AIDS Organisations said that there are alternatives to Truvada for PrEP in Australia.

PrEP taken as a pill once daily is known to reduce HIV transmission by 99 percent and while the well-known brand of Truvada has been delisted from the PBS subsidy as of April 1, 2020, there are other generic options still covered according to the National Association of People With HIV Australia:

“Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin Generic Health. The drugs manufactured by these three suppliers contain the same active ingredients as Truvada.”

Read Star Observer article